New variations guidelines: webinar for marketing authorisation holders (human), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 13 January 2026, 13:00 (CET) to 13 January 2026, 15:00 (CET)

Submitted by Anonymous (not verified) on 20 January 2026 - 9:49

New variations guidelines: webinar for marketing authorisation holders (human), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 13 January 2026, 13:00 (CET) to 13 January 2026, 15:00 (CET)

Human medicines European public assessment report (EPAR): Abiraterone Mylan, abiraterone acetate, Date of authorisation: 20/08/2021, Revision: 7, Status: Authorised

Submitted by Anonymous (not verified) on 19 January 2026 - 16:42

Human medicines European public assessment report (EPAR): Abiraterone Mylan, abiraterone acetate, Date of authorisation: 20/08/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 19 January 2026 - 16:39

Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Effentora, fentanyl, Date of authorisation: 04/04/2008, Revision: 33, Status: Authorised

Submitted by Anonymous (not verified) on 19 January 2026 - 16:38

Human medicines European public assessment report (EPAR): Effentora, fentanyl, Date of authorisation: 04/04/2008, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Brintellix, vortioxetine, Date of authorisation: 18/12/2013, Revision: 26, Status: Authorised

Submitted by Anonymous (not verified) on 19 January 2026 - 16:36

Human medicines European public assessment report (EPAR): Brintellix, vortioxetine, Date of authorisation: 18/12/2013, Revision: 26, Status: Authorised

HMA/EMA multi-stakeholder workshop on artificial intelligence (AI), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2025, 13:00 (CET) to 21 November 2025, 12:50 (CET)

Submitted by Anonymous (not verified) on 19 January 2026 - 16:30

HMA/EMA multi-stakeholder workshop on artificial intelligence (AI), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2025, 13:00 (CET) to 21 November 2025, 12:50 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness